“Conquer the Market: How Roman Discipline and Sun Tzu’s Strategy Can Supercharge Your Investments in Hot Industries” investing in Hot Theme Industries: A Blend of Roman Discipline and Sun Tzu’s Strategy Hot theme industries—such as artificial intelligence (AI), electric vehicles (EVs), renewable energy, and biotech—are attractive opportunities for investors. These sectors often promise explosive growth and innovation, but they can also be volatile and unpredictable. To naviga...
10baggerbamm
OP
Ginvest
:
that's your decision with vaccines these companies are 100% exonerated under current laws in the United States you can't sue any vaccine manufacturers now maybe that will change with Kennedy I don't know I think there should be accountability at all levels.
$Quantum-Si (QSI.US)$Quantum-Si is a pioneering company in the field of protein sequencing and analysis, with a focus on applying semiconductor technology to advance life sciences. Here’s a comprehensive overview of what Quantum-Si does, its technology, and its significance: Company Overview • Founded: 2013 • Founder: Dr. Jonathan Rothberg, a serial entrepreneur also known for inventing next-generation DNA sequencing (NGS). • Headquarters: Guilford, Connecticut, USA • ...
$bluebird bio (BLUE.US)$ bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition Positive 94.7% of evaluable patients achieved complete resolution of severe VOEs 86.8% of evaluable patients achieved complete resolution of VOEs 100% success rate in pediatric patients (10/10) for VOE resolution No stroke recurrence in patients with prior history through 9 y...
$bluebird bio (BLUE.US)$Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or Near-Normal Adult Hb Levels At ASH Meeting bluebird bio, Inc. (NASDAQ:BLUE) today announced updated data from patients with beta-thalassemia who require regular blood transfusions treated with be...
$bluebird bio (BLUE.US)$ bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition Sunday, 8th December at 12:30 pm Stable production of anti-sickling adult hemoglobin (HBAT87Q) and elimination or significant reduction of vaso-occlusive events sustained through last follow-up for all evaluable patients (n=38), underscoring potentially trans...
Ultratech :